Science International  Volume 4 Issue 3, 2016

Research Article

Plasmapheresis Effect on Respiratory Condition and Acidosis in Unstable Complex Patients with Pelvic and Long Bone Fracture
Ramin Azhough
Department of General Surgery, Tabriz University of Medical Science, Tabriz, Iran

Mohammad Basir Abolghasemie Fakhri
Department of General Surgery, Tabriz University of Medical Science, Tabriz, Iran

Samad Shams Vahdati
Department of Emergency Medicine, Road Traffic Injury Research Center, Tabriz University of Medical Science, Tabriz, Iran

Hadiseh Kavandi
Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran

Ali Shahavand
Department of General Surgery, Tabriz University of Medical Science, Tabriz, Iran

Background and Objective: After head trauma, pelvic fracture is the most common cause of death in multiple trauma patients. In cases with stable hemodynamic, sepsis or multi-organ failure is the cause of mortality. There are many efforts to improve these patients status. It seems that plasmapheresis by reducing inflammatory response could improve these patients status. The aim of current study is to evaluate the role of plasmapheresis on improving respiratory condition and acidosis in trauma patients with unstable complex pelvic fracture and long bones. Methodology: In this clinical trial, 12 patients (11 men and 1 woman) 30-60 years old with unstable complex pelvic fracture and long bones admitted to surgery ICU were evaluated. All patients received plasmapheresis and the plasmapheresis was repeated if needed. Atrial blood gas and hemodynamic findings before and after plasmapheresis were evaluated. Also, mortality and duration of hospital stay was recorded. Results: Thirty four sessions of plasmapheresis were performed in 12 patients. After plasmapheresis, systolic blood pressure was significantly increased (p = 0.02) and hear rate was significantly decreased (p = 0.001). Also, following plasmapheresis, oxygen saturation and blood pH were both increased (p<0.001 in both). The decrease in CO2 (p = 0.25) and increase in HCO3 (p = 0.22) was not significant. Mean ICU stay was 16.83±5.70 days and mean hospital stay was 19.50±6.04 days. There were three (25%) deaths. Conclusion: Plasmapheresis in patients with unstable complex pelvic fracture could improve acidosis and respiratory condition and so be effective in improving these patients condition.
    How to Cite:
Ramin Azhough, Mohammad Basir Abolghasemie Fakhri, Samad Shams Vahdati, Hadiseh Kavandi and Ali Shahavand , 2016. Plasmapheresis Effect on Respiratory Condition and Acidosis in Unstable Complex Patients with Pelvic and Long Bone Fracture. Science International, 4: 101-106
DOI: 10.17311/sciintl.2016.101.106


Trauma is a common cause of death and disability in young population in developed countries. In recent years, significant development is seen in dealing with traumatic patients including quick transfer of traumatic patient, on time resuscitation, special care and treatment of wounds. Pelvic fracture is the most common cause of death in multiple trauma patients after head trauma1,2.

Pelvic fractures usually occur after a car accident or a fall from a height and it is accompanied with fracture of other bones and injuries of other body tissues and viscera3-5. The main reason of death in patients with hip fracture is uncontrolled and uncontrollable bleeding and the main reason in cases of delayed death is pelvic or generalized sepsis and also multi-organ failure6,7.

There are many different causes that can lead to multi-organ failure such as infectious outcomes. It is suggested that inflammatory response of body to trauma induced stress can lead to failure of various organs and death through inflammatory cytokines production8-12. There are different mechanisms that inflammatory mediators can lead to organ failure. One of these mechanisms is increased capillary permeability which affects lungs more than all and leads to acute respiratory distress which is one of the main causes of death in traumatic patients10,12. Since the inflammatory response plays an important role in the serious consequences of trauma, interference and inhibition of inflammation can have a significant role in management of traumatic patients13.

There is a high risk of death in patients with hip and long bones fracture (33-57%). Since motor vehicles are a major contributor to the injured trauma patients in our country, 80-84% of hip fractures are due to the motor vehicle accidents14-16. Now-a-days, severe trauma which involved bone and soft tissue is one of the biggest challenges in medicine. Ninety percent of traumatic injuries are associated with bone fractures. The main reason of death in severe blunt trauma is multiple organ failure17,18. This failure can be due to infectious process which can lead to failure in lung and other organs. Additionally, inflammatory response of body that occurs after trauma and extensive injury of bone and soft tissue play a significant role in this organ failure.

According to the studies, inflammatory mediators especially TNF-α increases in first hours after trauma and it is the most important stimulator to start inflammatory process11,12. Plasmapheresis can also change the cytokine-anti cytokine pattern19.

The role of plasmapheresis in regulation of immune system includes modification of T-cells function, shifting to Th2 and suppression of IL2 and INF-γ production20-23.

It was shown in many studies and case reports that plasmapheresis had an important role in improvement of acidosis and finally the patient’s prognosis24-26.

Due to the significant role of inflammatory response in traumatic patients and effects of plasmapheresis in reduction of inflammatory mediators, it seems to be possible to improve general condition of patients with use of plasmapheresis and decrease of inflammatory response. There is no accessible study to evaluate this hypothesis. The aim of this study is to evaluate the effects of plasmapheresis in improvement of respiratory condition and acidosis as a part of the process of improving the management of trauma patients with complex and unstable fracture of hip and long bones.


This clinical trial to No. IRCT 2014082718946N1 has been registered in Iran’s clinical trials registering center to the address "".

Since no similar studies had been done, 12 cases were selected randomly with simple random sampling method. These 12 cases were chosen among patients between 15-65 years with complex unstable hip or long bones fracture who were referred to the hospital during the year of 2014 and hospitalized in ICU ward.

Inclusion criteria were having 15-65 years old, complex unstable hip or long bones fracture, indication for hospitalization in ICU, having respiratory distress and tachypnea, low oxygen saturation and acidosis.

Exclusion criteria were history of renal failure, low consciousness level (GCS<8) at admission, history of angioplasty, history of chronic lung disease such as chronic obstructive pulmonary disease and asthma, the need for surgical intervention and unstable hemodynamic.

Surgery and pelvic pack if there were indications for them and routine treatments for all patients were done according to surgery references. In critically ill patients (who had tachycardia, low blood pressure, low oxygen saturation and acidosis) despite surgical interventions who had normal hemoglobin and hematocrit and in the absence of clinical symptoms of active bleeding, plasmapheresis was performed. So, selection of patients done based on diagnosed as ill and no need for surgery.

Hospitalized patients with unstable complex hip fracture in ICU ward were evaluated in terms of respiratory status such as arterial blood gases, respiratory rate, presence of respiratory distress and patient’s attachment to ventilator at 6 am every day. Plasmapheresis was performed 2 h after these evaluations. The same tests were done at the end of plasmapheresis. Plasmapheresis was continued until the patient’s status was not changed or hemodynamic status was not deteriorated.

Plasmapheresis was performed with veno-venous access method. Heparin with dose of 200-300 U kg‾1 was used as anticoagulant. Two liters of patient’s plasma was replaced with 4 U of Fresh Frozen Plasma (FFP) in every session of plasmapheresis.

The most common complication of plasmapheresis is allergic reactions and the most dangerous one is anaphylactic reaction. In cases with this reaction subcutaneous epinephrine 1 mg kg‾1 was injected every 20-30 min up to 3 times. Aminophylline 16 mg kg‾1 was administered to relieve spasms. Plasmapheresis was continued until the patient had discharge indication from ICU ward in terms of respiratory status and acidosis. All patients were monitored in terms of coagulation tests, cardiovascular function, level of consciousness daily and 2 h after plasmapheresis.

So, effect of plasmapheresis on cardiovascular and respiratory function in patients with complex unstable hip fracture was evaluated. The number of hospitalized days in hospital (ICU or surgery ward) was calculated.

Statistical analysis: Descriptive methods such as frequency, percentage, Mean±Standard Deviation were used in order to statistical analysis. Wilcoxon parameter was used to compare quantitative variables before and after the intervention. All analysis was done with SPSS 17. The p<0.05 was considered significant.


In this study, plasmapheresis was done on 12 patients with complex unstable hip and long bones fracture. Patients were in the range of 30-60 years. All the patients were men except one of them. The most common cause of severe trauma was accidents. Basic findings of the patients were shown in Table 1. Generally, 34 times of plasmapheresis were done for all 12 patients.

Systolic blood pressure was increased and heart rate was decreased significantly. Changes in diastolic blood pressure and respiratory rate were not significant. Table 2 shows hemodynamic changes before and after plasmapheresis.

Oxygen saturation was increased significantly after plasmapheresis (p<0.001). Figure 1 shows oxygen saturation before and after plasmapheresis. Overall, there was improvement in oxygen saturation after plasmapheresis in 75% of cases.

After plasmapheresis, pH was significantly increased (p<0.001). Indeed, acidosis was corrected in majority of cases. Fig. 2 shows pH before and after plasmapheresis. The pH improvement was seen in 69.44% of cases.

Figure 1: Changes of oxygen saturation before and after plasmapheresis

Table 1: Basic findings of evaluated patients

Figure 2: pH changes before and after plasmapheresis

Table 2: Hemodynamic changes before and after plasmapheresis

The mean level of CO2 was 42.26±8.67 before plasmapheresis and 40.4±8.28 after that. Despite decrease in CO2 level after plasmapheresis, the difference was not significant (p = 0.25). Improvement of CO2 level was seen in 47.22% of cases.

The mean HCO3 level was 19.87±5.97 before plasmapheresis and 20.36±5.59 after that. Despite increase in HCO3 level after plasmapheresis, the difference was significant (p = 0.22). Improvement was seen in 55.55% of cases after plasmapheresis.

The mean PO2 level was 75.02±20.53 before plasmapheresis and 89.22±18.54 after that. It was significantly increased after treatment (p = 0.009).

The mean FiO2 level was 64.68±18.48 before plasmapheresis and 60.20±17.01 after that. There was not any significant change in FiO2 levels before and after treatment (p = 0.15).

The mean period of hospitalization in ICU ward was 16.83±5.70 days with the median of 9. The mean period of hospitalization in surgery ward was 4.16±0.97 days with the median of 4. The mean period of hospitalization was 19.50±6.04 days. There were 3 deaths among 12 patients (25%). There were no death in patients who response to first time of treatment. Indeed, in 3 cases of death, 5 times of plasmapheresis was done in 2 cases and 4 times were done in one case in which none of them were effective.


Effect of plasmapheresis on patients with complex hip or long bone fractures was evaluated for the first time in this study. Thirty four times of plasmapheresis were done on 12 patients. Respiratory status, general condition and hope to survive of patients were improved with this treatment.

The most common cause of complications occurred after trauma is stress and body inflammatory response and inflammatory cytokines production8,9. Increased inflammatory mediators in first hours after trauma was shown11,12. So, it seems possible to improve the clinical status of patients through adjustment of the inflammatory response.

Plasmapheresis has a regulatory effect on inflammatory response, cellular and humoral immunity20-23,27. It was shown that plasmapheresis can reduce the blood level of inflammatory mediators (18) and control of blood level of immune system stimulatory cytokines28.

This is the first study that evaluates the effect of plasmapheresis on the improvement of acidosis and respiratory function of traumatic patients. Results of this study showed that plasmapheresis can improve acidosis and oxygen saturation.

In a case report, it was shown that plasmapheresis can be effective in improvement of acidosis and rapid treatment of acute respiratory distress syndrome29.

In another report, one-time treatment with plasmapheresis was accompanied with rapid improvement in hemodynamic status, improvement of lactic acidosis during 24 h and finally complete recovery of the patient24.

Complete recovery in terms of arterial gasses and general condition after treatment with plasmapheresis was reported in 3 cases of amitriptyline toxicity25.

In previous studies, it was shown that patients with hip and long bone fractures had a high mortality rate (33-57%)20-22. In this study mortality rate after appropriate therapy with plasmapheresis was 25%.

Only a single time of treatment with plasmapheresis was effective in 6 patients. In the others, 2-5 times of treatment was done. It was not effective in 3 of patients and so they died.

In previous studies on patients with the guillain-barre syndrome, four times of plasmapheresis were more effective than 2 times in patients without the need for ventilation and in ventilated patients there was no significant difference between 4 and 6 times of plasmapheresis30. It seems that times of plasmapheresis depended on clinical status of the patient and his/her diagnosis.


Plasmapheresis can be effective in improvement of acidosis and respiratory status in patients with unstable complex hip fracture.

According to the results of this study, use of plasmapheresis is recommended in patients who didn’t response to routine therapies.

Since this study is the first one in this field, further studies with larger sample size are recommended to achieve better and more accurate results.


  1. Polinder, S., J.A. Haagsma, H. Toet, M.J. Brugmans, E.F. van Beeck and EUROCOST and APOLLO Reference Groups, 2010. Burden of injury in childhood and adolescence in 8 European countries. BMC Public Health, Vol. 10. 10.1186/1471-2458-10-45

  2. Soreide, K., A.J. Kruger, A.L. Vardal, C.L. Ellingsen, E. Soreide and H.M. Lossius, 2007. Epidemiology and contemporary patterns of trauma deaths: changing place, similar pace, older face. World J. Surg., 31: 2092-2103

  3. Stein, D.M., J.V. O’Connor, J.A. Kufera, S.M. Ho, P.C. Dischinger, C.E. Copeland and T.M. Scalea, 2006. Risk factors associated with pelvic fractures sustained in motor vehicle collisions involving newer vehicles. J. Trauma Acute Care Surg., 61: 21-31

  4. Silber, J.S., J.M. Flynn, K.M. Koffler, J.P. Dormans and D.S. Drummond, 2001. Analysis of the cause, classification and associated injuries of 166 consecutive pediatric pelvic fractures. J. Pediatr. Orthopaedics, 21: 446-450

  5. Van Vugt, A.B. and A. van Kampen, 2006. An unstable pelvic ring: The killing fracture. Bone Joint J., 88: 427-433

  6. Ciesla, D.J., E.E. Moore, J.L. Johnson, J.M. Burch, C.C. Cothren and A. Sauaia, 2005. A 12-year prospective study of postinjury multiple organ failure: Has anything changed? Arch. Surg., 140: 432-438

  7. Dewar, D.C., S.M. Tarrant, K.L. King and Z.J. Balogh, 2013. Changes in the epidemiology and prediction of multiple-organ failure after injury. J. Trauma Acute Care Surg., 74: 774-779

  8. Waydhas, C., D. Nast-Kolb, M. Jochum, A. Trupka and S. Lenk et al., 1992. Inflammatory mediators, infection, sepsis and multiple organ failure after severe trauma. Arch. Surg., 127: 460-467

  9. Plank, L.D. and G.L. Hill, 2000. Sequential metabolic changes following induction of systemic inflammatory response in patients with severe sepsis or major blunt trauma. World J. Surg., 24: 630-638

  10. Tatsumi, T., S. Matoba, A. Kawahara, N. Keira and J. Shiraishi et al., 2000. Cytokine-induced nitric oxide production inhibits mitochondrial energy production and impairs contractile function in rat cardiac myocytes. J. Am. Coll. Cardiol., 35: 1338-1346

  11. Spielmann, S., T. Kerner, O. Ahlers, D. Keh, M. Gerlach and H. Gerlach, 2001. Early detection of increased tumour necrosis factor alpha (TNFα) and soluble TNF receptor protein plasma levels after trauma reveals associations with the clinical course. Acta Anaesthesiol. Scandinavica, 45: 364-370

  12. Suter, P.M., S. Suter, E. Girardin, P. Roux-Lombard, G.E. Grau and J.M. Dayer, 1992. High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am. Rev. Respiratory Dis., 145: 1016-1022

  13. Wo, C.C., W.C. Shoemaker, P.L. Appel, M.H. Bishop, H.B. Kram and E. Hardin, 1993. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Critical Care Med., 21: 218-223

  14. Balogh, Z., K.L. King, P. Mackay, D. McDougall and S. Mackenzie et al., 2007. The epidemiology of pelvic ring fractures: A population-based study. J. Trauma Acute Care Surg., 63: 1066-1073

  15. Demetriades, D., M. Karaiskakis, K. Toutouzas, K. Alo, G. Velmahos and L. Chan, 2002. Pelvic fractures: Epidemiology and predictors of associated abdominal injuries and outcomes. J. Am. College Surgeons, 195: 1-10

  16. O’Sullivan, R.E.M., T.O. White and J.F. Keating, 2005. Major pelvic fractures: Identification of patients at high risk. J. Bone Joint Surg. Br., 87: 530-533

  17. Evans, J.A., K.J.P. van Wessem, D. McDougall, K.A. Lee, T. Lyons and Z.J. Balogh, 2010. Epidemiology of traumatic deaths: Comprehensive population-based assessment. World J. Surg., 34: 158-163

  18. Minei, J.P., J. Cuschieri, J. Sperry, E.E. Moore and M.A. West et al., 2012. The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock. Critical Care Med., 40: 1129-1135

  19. Scholmerich, J., 1996. Interleukins in acute pancreatitis. Scand. J. Gastroenterol., 31: 37-42

  20. Szczepiorkowski, Z.M., J.L. Winters, N. Bandarenko, H.C. Kim and M.L. Linenberger et al., 2010. Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the apheresis applications committee of the American Society for Apheresis. J. Clin. Apheresis, 25: 83-177

  21. Goto, H., H. Matsuo, S. Nakane, H. Izumoto, T. Fukudome, C. Kambara and N. Shibuya, 2001. Plasmapheresis affects T helper type-1/T helper type-2 balance of circulating peripheral lymphocytes. Ther. Apheresis Dialysis, 5: 494-496

  22. Kambara, C., H. Matsuo, T. Fukudome, H. Goto and N. Shibuya, 2002. Miller fisher syndrome and plasmapheresis. Ther. Apheresis, 6: 450-453

  23. Shariatmadar, S., M. Nassiri and V. Vincek, 2005. Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura. Am. J. Hematol., 79: 83-88

  24. Levin, P.D., V. Levin, C. Weissman, C.L. Sprung and D. Rund, 2015. Therapeutic plasma exchange as treatment for propofol infusion syndrome. J. Clin. Apheresis, 30: 311-313

  25. Bayrakci, B., S. Unal, M. Erkocoglu, H.Y. Gingor and S. Aksu, 2007. Case reports of successful therapeutic plasma exchange in severe amitriptyline poisoning. Ther. Apheresis Dial., 11: 452-454

  26. Ezidiegwu, C., Z. Spektor, M.R. Nasr, K.C. Kelly and L.G. Rosales, 2008. A case report on the role of plasma exchange in the management of a massive amlodipine besylate intoxication. Ther. Apheresis Dial., 12: 180-184

  27. Schmidt, J., S. Mann, V.D. Mohr, R. Lampert, U. Firla and H. Zirngibl, 2000. Plasmapheresis combined with continuous venovenous hemofiltration in surgical patients with sepsis. Intensive Care Med., 26: 532-537

  28. Dutcher, J.P., 2013. Therapeutic Cytapheresis, Plasmapheresis and Plasma Exchange in Neoplastic Diseases of the Blood. In: Neoplastic Diseases of the Blood, Wiernik, P.H., J.M. Goldman, J.P. Dutcher and R.A. Kyle (Eds.). Springer, New York, USA., ISBN: 9781461437642, pp: 1241-1249.

  29. Kohli, R.S., W. Bleibel, A. Shetty and U. Dhanjal, 2006. Plasmapheresis in the treatment of hypertriglyceridemic pancreatitis with ARDS. Dig. Dis. Sci., 51: 2287-2291

  30. Raphael, J.C., S. Chevret, R.A.C. Hughes and D. Annane, 2002. Plasma exchange for Guillain-Barre syndrome. Cochrane Database Syst. Rev., Vol. 2. 10.1002/14651858.CD001798 >

Science International © 2017